Jasmin Barman-Aksozen

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin.

New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin.

Journal: Expert opinion on pharmacotherapy

Published: March 26, 2026

From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.

From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.

Journal: JAAD case reports

Published: January 16, 2026

Letter to the Editor - Qualitative evidence submitted by patients to NICE: need for more quality or unrealistic and unfair requirements?

Letter to the Editor - Qualitative evidence submitted by patients to NICE: need for more quality or unrealistic and unfair requirements?

Journal: Journal of comparative effectiveness research

Published: October 30, 2025

Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study.

Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study.

Journal: Orphanet journal of rare diseases

Published: October 05, 2025

New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective.

New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective.

Journal: Orphanet journal of rare diseases

Published: May 08, 2025

Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels-a single-centre retrospective study.

Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels-a single-centre retrospective study.

Journal: Frontiers in molecular biosciences

Published: October 14, 2024

Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England.

Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England.

Journal: International journal of environmental research and public health

Published: April 17, 2024

Editorial on the Special Issue "Heme Metabolism and Porphyria".

Editorial on the Special Issue "Heme Metabolism and Porphyria".

Journal: Life (Basel, Switzerland)

Published: March 22, 2024

Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.

Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 08, 2024

First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent Porphyria.

First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent Porphyria.

Journal: Life (Basel, Switzerland)

Published: August 14, 2023

Letter to the Editor: Contrasting effect of iron supplementation in protoporphyria.

Letter to the Editor: Contrasting effect of iron supplementation in protoporphyria.

Journal: Hepatology (Baltimore, Md.)

Published: August 13, 2023

Dersimelagon in Erythropoietic Protoporphyrias.

Dersimelagon in Erythropoietic Protoporphyrias.

Journal: The New England journal of medicine

Published: June 28, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026